Haemoptysis in pregnancy may be due to a myriad of causes, including pulmonary embolism, heart failure, vasculitides and infective or post-infective aetiologies. Pulmonary arteriovenous malformations (PAVMs) are a rare cause of massive haemoptysis that involve an abnormal communication between the pulmonary arteries and the pulmonary veins. The majority of PAVMs are congenital and associated with hereditary haemorrhagic telangiectasia (HHT). To illustrate the complexity of the diagnosis and management of PAVM in pregnancy, we report the case of a 32-year-old woman presenting with massive haemoptysis at 36 weeks of gestation.
A 32-year-old woman presented with a 1-day history of ~500 mL of haemoptysis at 36 weeks' gestation. This was her first episode of haemoptysis, which was preceded by a dry cough for 6 months. She did not experience chest pain, orthopnoea, paroxysmal nocturnal dyspnoea or constitutional symptoms. Her two previous pregnancies were un complicated. She tested negative for HIV during antenatal screening and she had no comorbidities. She was not using any chronic medication or illicit drugs. She had a 10 pack-year smoking history and consumed alcohol in moderation prior to her pregnancy. She had no significant family history, travel history or environmental exposure.
On examination, her blood pressure was 130/80 mmHg, heart rate 90 beats per minute, respiratory rate 24 breaths per minute and temperature 36°C. Her pulse oximetry measured 97% on ambient air. She exhibited digital clubbing but had no features to suggest deep vein thrombosis, petechia, purpura, telangiectasia or connective tissue disease. Her respiratory examination revealed a patent airway with bilateral equal breath sounds and no added sounds. Her heart sounds were normal with no murmurs. Her abdomen was soft and non-tender. Her neurological examination was normal.
She had a normal full blood count, renal function, liver function, coagulation studies, vasculitic screen and urinalysis. Her sputum microscopy, culture and mycobacterium tuberculosis polymerase chain reaction (GeneXpert MTB/RIF PCR) were negative. Her chest X-ray and computed tomography pulmonary angiogram (CTPA) with 3D reconstruction are shown in Figs 1, 2 and 3, respectively. In view of the severity of the patient's symptoms and her abnormal chest X-ray, CTPA was regarded as the imaging modality of choice. The CTPA demonstrated a large pulmonary arteriovenous malformation (PAVM). The patient subsequently underwent successful coiling of her PAVM (Fig. 4) and had an uncomplicated vaginal delivery. Repeat CTPA confirmed retraction of the aneurysmal sac. Prior to discharge, the patient was counselled regarding the risks related to PAVM in future pregnancy and was offered contraception.
Discussion
Haemoptysis in pregnancy may be due to a myriad of causes, including pulmonary embolism, heart failure, vasculitides and infective or post-infective aetiologies. Although no standardised definition exists, massive haemoptysis is generally associated with ~500 mL of expectorated blood in a 24-hour period, or a rate of haemoptysis greater than ~200 mL per hour. [1] PAVMs are a rare cause of massive haemoptysis but should be considered in the differential diagnosis of a patient presenting with this clinical problem.
PAVMs were first described in 1897. [2] They consist of abnormal communications between the pulmonary arteries and the pulmonary veins. Ninety-five percent of the feeding arteries arise from the pulmonary circulation, while 5% arise from the bronchial artery, internal mammary artery or descending aorta. Furthermore, 53 -70% of PAVMs are found in the lower lobes and are commonly multiple. [3] Over 80% of PAVMs are congenital, and of these, 47 -96% (depending on the context) are associated with the autosomal dominant disorder hereditary haemorrhagic telangiectasia (HHT), also known as OslerWeber-Rendu disease. Conversely, it is estimated that, overall, 5 -15% with HHT have a PAVM. [4] Secondary or acquired causes of PAVM, although uncommon, have also been reported ( Table 1) .
The pathogenesis of PAVMs is poorly understood. [4] It is proposed that a defect in the terminal arteriole occurs, leading to dilatation of thin-walled capillary sacs. Blood then bypasses the normal oxygen-exchanging pulmonary capillary bed, returning to the pulmonary veins in a desaturated state. The fundamental defect is therefore a right-to-left shunt. [5] Dyspnoea, especially with exercise, develops over many years. [6] In severe cases, dyspnoea in the upright position (platypnoea) with associated cyanosis (orthodeoxia) is present. Haemoptysis occurs rarely, accounting for 0.2% of all causes of haemoptysis, [7] which may sometimes be massive. On examination, patients may demonstrate digital clubbing while the presence of telangiectasia is a valuable clue to the association with HHT. Machinery murmurs or bruits are heard over large PAVMs. Hypoxia, if present, does not correct fully after the administration of 100% oxygen. PAVMs are also associated with a variety of complications, some of which are life-threatening, including strokes, brain abscesses and heart failure.
Chest X-ray is an important diagnostic tool and shows abnormalities in more than 90% of patients. [8] CTPA, however, remains the gold standard for evaluating the angio-architecture of the PAVM, and when combined with 3D helical scanning can produce images of the entire vascular structure with a sensitivity of up to 95%. [9] The classical radiographical features of PAVM are a rounded, sharply defined mass of uniform density, frequently lobulated, and ranging from 1 -5 cm in diameter. There may sometimes be a connecting vessel radiating from the hilum.
Until 1977, surgery was the only method of treatment, in which ligation, local excision, Systemic amyloidosis lobectomy or pneumonectomy was performed. Nowadays, embolotherapy is the treatment of choice as it avoids major surgery, anaesthesia, loss of lung parenchyma and additional cost. [10] Moreover, embolotherapy has comparable success rates with surgery. [11] It is performed by catheterisation of the feeding artery and either coiling or balloon deployment into the PAVM. The indications and complications of embolotherapy are listed in Table 2 .
Untreated, PAVMs confer a high mortality risk of up to ~30%. [12] Furthermore, genetic counselling is an important aspect of management in patients with HHT. [13] PAVM in pregnancy PAVM in pregnancy is rare and is associated with an increased rate of growth and complications such as haemoptysis. [14] This is due to the increase in blood volume and the vasodilatory effect of pregnancy hormones, most marked during the second trimester, which leads to increased pulmonary blood flow, PAVM dilatation and subsequent rupture. Therefore, female patients with a history of PAVM must be counselled regarding the substantial risks associated with pregnancy and be offered suitable contraception.
Conclusion
PAVM is a rare cause of massive haemoptysis, however it must be considered in the differential diagnosis of a patient presenting with this clinical problem. Embolotherapy is the treatment of choice for symptomatic or large lesions. Furthermore, PAVMs are associated with an increased rate of complications in pregnancy, and female patients should be counselled regarding this risk and offered contraception.
